IRIS UniCatt

Cauda, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.227
EU - Europa 15.389
AS - Asia 13.123
SA - Sud America 2.487
AF - Africa 336
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 28
AN - Antartide 1
Totale 49.626
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.720
SG - Singapore 5.860
DE - Germania 4.722
CN - Cina 3.707
SE - Svezia 2.186
BR - Brasile 2.027
IT - Italia 1.856
FR - Francia 1.511
PL - Polonia 1.236
UA - Ucraina 1.176
VN - Vietnam 1.040
GB - Regno Unito 741
IE - Irlanda 614
IN - India 446
FI - Finlandia 406
ID - Indonesia 402
TR - Turchia 332
RU - Federazione Russa 317
JP - Giappone 304
HK - Hong Kong 241
CA - Canada 225
AR - Argentina 171
BD - Bangladesh 168
MX - Messico 164
NL - Olanda 115
IQ - Iraq 114
AT - Austria 104
ZA - Sudafrica 101
BE - Belgio 88
EC - Ecuador 82
ES - Italia 67
IR - Iran 57
MA - Marocco 55
VE - Venezuela 53
CO - Colombia 52
PK - Pakistan 51
KR - Corea 42
UZ - Uzbekistan 40
PH - Filippine 38
JO - Giordania 36
SA - Arabia Saudita 34
TN - Tunisia 32
CL - Cile 30
LT - Lituania 30
CH - Svizzera 29
KE - Kenya 29
CI - Costa d'Avorio 26
EG - Egitto 26
JM - Giamaica 26
AU - Australia 25
EU - Europa 23
PY - Paraguay 22
BG - Bulgaria 21
AZ - Azerbaigian 20
KZ - Kazakistan 20
UY - Uruguay 20
AE - Emirati Arabi Uniti 19
AL - Albania 19
CZ - Repubblica Ceca 19
MY - Malesia 19
NP - Nepal 18
GR - Grecia 16
PE - Perù 15
CR - Costa Rica 14
DZ - Algeria 14
BZ - Belize 13
ET - Etiopia 13
IL - Israele 13
PT - Portogallo 13
TW - Taiwan 13
BO - Bolivia 12
HN - Honduras 12
OM - Oman 12
PA - Panama 12
RO - Romania 12
DK - Danimarca 11
HU - Ungheria 11
LB - Libano 10
DO - Repubblica Dominicana 9
EE - Estonia 9
NG - Nigeria 9
AO - Angola 8
KG - Kirghizistan 8
NZ - Nuova Zelanda 8
PS - Palestinian Territory 8
NI - Nicaragua 7
VA - Santa Sede (Città del Vaticano) 7
BH - Bahrain 6
LV - Lettonia 6
MD - Moldavia 6
SN - Senegal 6
BY - Bielorussia 5
HR - Croazia 5
KW - Kuwait 5
LA - Repubblica Popolare Democratica del Laos 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
BB - Barbados 4
GT - Guatemala 4
LU - Lussemburgo 4
Totale 49.529
Salva come PNG Salva come JPEG
Città #
Singapore 2.972
Chandler 2.416
Ashburn 2.147
San Jose 1.560
Jacksonville 771
Warsaw 653
Hangzhou 634
Dublin 603
New York 578
San Mateo 573
Beijing 571
Kraków 551
Nanjing 438
Ann Arbor 394
Jakarta 371
Dearborn 358
Ho Chi Minh City 348
Wilmington 347
Los Angeles 344
Houston 336
Lauterbourg 336
Woodbridge 313
Nürnberg 295
Milan 292
Hefei 266
Tokyo 256
Boston 247
Rome 239
Hanoi 236
Izmir 233
The Dalles 214
Hong Kong 208
Dallas 196
Frankfurt am Main 195
Redmond 192
Lawrence 189
Moscow 188
Seattle 185
Cattolica 184
Fairfield 182
Nanchang 177
São Paulo 175
Munich 167
Marseille 153
Princeton 151
Chicago 141
Redwood City 139
Buffalo 136
Lancaster 127
Santa Clara 120
Bremen 110
Shenyang 103
Boardman 102
Helsinki 100
Kunming 91
Orem 85
Brussels 82
London 82
Mountain View 77
Hebei 75
Norwalk 71
Tianjin 70
Montreal 69
Rio de Janeiro 69
Paris 63
University Park 63
Cambridge 62
Kent 61
Vienna 61
Changsha 60
Johannesburg 60
Fremont 59
Guangzhou 59
Atlanta 57
Brooklyn 57
Shanghai 57
Council Bluffs 56
Amsterdam 55
Da Nang 55
Nuremberg 55
Toronto 55
Leawood 53
Augusta 52
Denver 52
Zhengzhou 52
Jiaxing 51
Pune 50
Düsseldorf 47
Chennai 46
Phoenix 45
Mexico City 44
Haiphong 43
Belo Horizonte 42
Washington 42
San Francisco 40
Turku 40
Jinan 38
Manchester 38
North Bergen 38
Poplar 38
Totale 26.129
Salva come PNG Salva come JPEG
Nome #
New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years 494
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 396
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 383
Factors associated with mortality in bacteremic patients with hematologic malignancies. 374
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 359
Factors associated with mortality in bacteremic patients with haematologic malignancies 355
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 355
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 323
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 309
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 306
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 279
Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients 278
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 269
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 264
La pandemia di COVID-19: un limite o una frontiera per la Legge 24/2017? 263
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 260
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility 253
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 238
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 234
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 231
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 229
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 227
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 225
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 223
Factors associated with mortality in bacteremic patients with hematologic malignancies. 218
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 218
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 218
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 217
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 215
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 210
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 208
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 207
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 207
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 205
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 202
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 199
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis 198
A real-time integrated framework to support clinical decision making for covid-19 patients 198
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects 194
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 194
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 193
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 193
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 192
Malnutrition in COVID-19 survivors: prevalence and risk factors 190
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 190
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 189
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 188
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 186
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 186
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 186
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS 184
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 183
Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection 182
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 182
Variability of raltegravir plasma levels in the clinical setting 182
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 182
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. 181
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies 181
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 180
Malnutrition in COVID-19 survivors: prevalence and risk factors 178
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 178
Psychopathological profile in COVID-19 patients including healthcare workers: the implications 177
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 177
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. 176
Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy 176
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 176
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. 175
Comparison of expression vectors in Lactobacillus reuteri strains 175
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 175
COVID-19 atypical Parsonage-Turner syndrome: a case report 174
Initial antifungal strategy does not correlate with mortality in patients with candidemia 174
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome 173
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection 171
Impact of antibiotic stewardship on perioperative antimicrobial prophylaxis 171
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators 169
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients 168
Predictors of successful genotype-guided antiretroviral therapy in treatment-experienced individuals over calendar year: a cohort study 167
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 167
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 166
The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study 166
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 166
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 165
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 164
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 163
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 163
Attitudes and practices of dentists treating HIV patients in HAART era. 162
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 162
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 162
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 161
Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy. 159
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 158
Cognitive reserve and neuropsychological functioning in older HIV-infected people 157
Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections 156
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series 156
Sarilumab use in severe SARS-CoV-2 pneumonia 156
Dental hygienists behaviour towards HIV-positive patients in highly active antiretroviral therapy era: a pilot survey 155
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 155
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 155
Virological suppression reduces clinical progression in patients with multiclass-resistant HIV type 1 154
Totale 20.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 189.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021495 0 0 0 0 0 0 0 0 0 0 434 61
2021/20223.174 258 261 85 241 136 109 70 519 127 222 487 659
2022/20236.624 841 947 544 964 517 744 282 524 839 125 211 86
2023/20243.170 138 883 98 248 128 522 190 100 53 109 368 333
2024/20256.296 136 203 504 209 622 219 180 343 1.057 546 1.212 1.065
2025/202615.652 2.466 461 1.009 1.919 2.905 850 2.817 835 1.089 1.191 110 0
Totale 50.147